title: Evolution of proliferation and the angiogenic switch in tumors with high clonal diversity.
abstract: Natural selection among tumor cell clones is thought to produce hallmark properties of malignancy. Efforts to understand evolution of one such hallmark--the angiogenic switch--has suggested that selection for angiogenesis can "run away" and generate a hypertumor, a form of evolutionary suicide by extreme vascular hypo- or hyperplasia. This phenomenon is predicted by models of tumor angiogenesis studied with the techniques of adaptive dynamics. These techniques also predict that selection drives tumor proliferative potential towards an evolutionarily stable strategy (ESS) that is also convergence-stable. However, adaptive dynamics are predicated on two key assumptions: (i) no more than two distinct clones or evolutionary strategies can exist in the tumor at any given time; and (ii) mutations cause small phenotypic changes. Here we show, using a stochastic simulation, that relaxation of these assumptions has no effect on the predictions of adaptive dynamics in this case. In particular, selection drives proliferative potential towards, and angiogenic potential away from, their respective ESSs. However, these simulations also show that tumor behavior is highly contingent on mutational history, particularly for angiogenesis. Individual tumors frequently grow to lethal size before the evolutionary endpoint is approached. In fact, most tumor dynamics are predicted to be in the evolutionarily transient regime throughout their natural history, so that clinically, the ESS is often largely irrelevant. In addition, we show that clonal diversity as measured by the Shannon Information Index correlates with the speed of approach to the evolutionary endpoint. This observation dovetails with results showing that clonal diversity in Barrett's esophagus predicts progression to malignancy.
authors.affiliation: Department of Life Sciences, Scottsdale Community College, Scottsdale, Arizona, United States of America.
authors.forename: Scott T
authors.initials: ST
authors.lastname: Bickel
authors.affiliation: Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona, United States of America.
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Juliano
authors.affiliation: Department of Life Sciences, Scottsdale Community College, Scottsdale, Arizona, United States of America; School of Mathematical and Statistical Sciences, Arizona State University, Tempe, Arizona, United States of America.
authors.forename: John D
authors.initials: JD
authors.lastname: Nagy
mesh_terms: D049109:Cell Proliferation; D002999:Clone Cells; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000098:blood supply* / Q000473:pathology*; D009389:Neovascularization, Pathologic / Q000473:pathology*; D013997:Time Factors
references.citation: Integr Comp Biol. 2007 Aug;47(2):317-28
references.pmid: 21672841
references.citation: FASEB J. 1999 Jan;13(1):9-22
references.pmid: 9872925
references.citation: Nat Rev Cancer. 2006 Dec;6(12):924-35
references.pmid: 17109012
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: J Cell Sci. 1969 May;4(3):645-54
references.pmid: 5817088
references.citation: Biochim Biophys Acta. 2000 Mar 6;1474(1):75-87
references.pmid: 10699493
references.citation: Trends Ecol Evol. 1992 Jun;7(6):198-202
references.pmid: 21236007
references.citation: Acta Biotheor. 2005;53(3):241-64
references.pmid: 16329010
references.citation: Development. 1998 May;125(9):1591-8
references.pmid: 9521897
references.citation: Biosci Rep. 2002 Oct-Dec;22(5-6):501-11
references.pmid: 12635847
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Nature. 1992 Oct 29;359(6398):845-8
references.pmid: 1279432
references.citation: Nat Rev Cancer. 2003 Jun;3(6):401-10
references.pmid: 12778130
references.citation: Science. 1999 Jun 18;284(5422):1994-8
references.pmid: 10373119
references.citation: Nat Rev Cancer. 2005 Oct;5(10):773-85
references.pmid: 16195750
references.citation: Nat Genet. 2006 Apr;38(4):468-73
references.pmid: 16565718
references.citation: Cell. 1996 Aug 9;86(3):353-64
references.pmid: 8756718
references.citation: Mol Cell. 2008 May 23;30(4):393-402
references.pmid: 18498744
references.citation: Am J Pathol. 1996 Feb;148(2):473-83
references.pmid: 8579110
references.citation: Theor Popul Biol. 1981 Jun;19(3):420-33
references.pmid: 7256682
references.citation: J Clin Invest. 2002 Mar;109(6):777-85
references.pmid: 11901186
references.citation: Semin Cancer Biol. 2009 Oct;19(5):329-37
references.pmid: 19482086
references.citation: Math Biosci Eng. 2005 Apr;2(2):381-418
references.pmid: 20369929
references.citation: Bull Math Biol. 2004 Jul;66(4):663-87
references.pmid: 15210312
references.citation: Math Biosci Eng. 2012 Oct;9(4):843-76
references.pmid: 23311425
references.citation: Annu Rev Biochem. 1998;67:821-55
references.pmid: 9759505
references.citation: J Neuropathol Exp Neurol. 2006 Jun;65(6):529-39
references.pmid: 16783163
references.citation: Trends Ecol Evol. 1997 Apr;12(4):128-31
references.pmid: 21238006
references.citation: Pharmacol Ther. 2013 Mar;137(3):318-30
references.pmid: 23159371
references.citation: Nat Rev Cancer. 2011 Feb;11(2):85-95
references.pmid: 21258394
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1804-9
references.pmid: 16443685
references.citation: Nature. 2012 Jan 18;481(7381):306-13
references.pmid: 22258609
references.citation: J Neurooncol. 2000 Oct-Nov;50(1-2):121-37
references.pmid: 11245272